SuperworthDrugs Made In America Acquisition II market cap DMII
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $649.1M
- Highest close in our data
- $655.1M
- Feb 2026
Drugs Made In America Acquisition II is worth $649.1M at the close on Oct 23, 2026, at $10.19 a share.
That is up 0% over the last year.
Its highest close in our data was $655.1M in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $649.1M | $637.6M | $655.1M | −0% |
| 2025 | $649.2M | $647.2M | $650.5M | n/a |
Against its peers
Companies in Financial Services nearest Drugs Made In America Acquisition II's size, closest first, today.
| Company | Market cap |
|---|---|
| DMIIDrugs Made In America Acquisition II | $649.1M |
| PRTHPriority Technology | $644.7M |
| TCBXThird Coast Bancshares | $662.9M |
| ACNBAcnb | $665.3M |
| CBNKCapital Bancorp | $672.6M |
| CARECarter Bankshares | $677.6M |
| BHBBar Harbor Bankshares | $678.4M |
| RRBIRed River Bancshares | $679.9M |
| MSBIMidland States Bancorp | $684.4M |
| GCBCGreene County Bancorp | $606.3M |
| FBIZFirst Business Financial Services | $606.1M |
| Peer median | $669M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Drugs Made In America Acquisition II
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.